Drugs Made In America Acquisition Corp
Price
FilingsNewest: 8-K, Material agreementSep 14 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: DMII, CHAR, ATII→
From the filings
Figures
- Net income
- $6.1Mlast 12 months
- Operating cash flow
- −$379,193last 12 months
- Cash and equivalents
- $20,280at the last balance sheet
- Shares outstanding
- 10.7M shareson issue